Moderna
Search results
Vertex Pharmaceuticals is a biotechnology company that creates transformative medicines for serious diseases. Learn more about its innovation, news, careers and grants.
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in South Boston, Massachusetts, and three research facilities, in San Diego ...
Vertex ranked #3 in the extra large company category in 2024. For the 11th time in the past 12 years, Vertex’s San Diego site was named to the ’s Best Places to Work list. In 2023, we ranked #12 in the Mega Employer category. Vertex Pharmaceuticals strikes at the core of serious diseases to change people's lives – learn about our mission ...
Vertex Pharmaceuticals | 372,535 followers on LinkedIn. The Science of Possibility | Vertex is a global biotechnology company that invests in scientific innovation to create transformative ...
Vertex Pharmaceuticals develops therapies to address cystic fibrosis and other diseases. The company was founded in 1989 in Cambridge, Massachusetts and has 5,400 employees. It has research ...
The Science of Possibility. At Vertex, we work with leading researchers, doctors, public health experts and other collaborators who share our vision for transforming the lives of people with serious diseases, their families and society. 20 Bay Street, Suite 1520. Toronto, Ontario M5J 2N8.
May 30, 2024 · But by April, the first patients had started the treatment process. Vertex expects revenues to top $10 billion in 2024, largely powered by another remarkable drug, cystic fibrosis treatment ...
Oct 3, 2023 · BOSTON--(BUSINESS WIRE)--Oct. 3, 2023-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today presented longer-term data on patients dosed in Parts A and B of its Phase 1/2 clinical trial of VX-880, an investigational stem cell-derived, fully differentiated islet cell therapy in people with type 1 diabetes (T1D) with impaired hypoglycemic awareness and severe hypoglycemic events (SHEs). Prior to VX-880 treatment, all six patients enrolled had long-standing T1D with no endogenous insulin ...
Read More. Jul 01 2024. Vertex to Announce Second Quarter 2024 Financial Results on August 1. Read More. Jun 21 2024. Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions. Read More. Jun 14 2024.
Vertex Pharmaceuticals | 371,698 followers on LinkedIn. The Science of Possibility | Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research ...
